In early February the German government’s main vaccination watchdog, the Paul Ehrlich Institute, published a paper warning that in coronavirus infections, the virus’ spiked proteins cause cell fusions with dangerous complications in various organs.
Vaccines produce these same spiked proteins in the cells of vaccinated persons, i.e., they also produce cell fusions. Coronavirus surface proteins alone can fuse neighboring cells, which can form a cluster of up to 100 fused cells and perish in the process.
The research team at the Paul Ehrlich Institute, of which its director Klaus Cichutek is also a member, submitted the paper to the scientific journal iScience on October 21 last year. On February 5, the journal accepted it for publication. It is entitled: “Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion from Without” (*).
The study demonstrates that the mere presence of isolated spike proteins, without the viral body, can lead to large-scale cell fusions. Such reactions have been known for a long time, for example, since the 1960s with the Newcastle disease virus, or later with HIV viruses, where even parts of the envelopes are sufficient to cause such pathological cell fusions. Measles virus is also considered responsible for these virus-induced cell aggregates in the brain, and herpes viruses stimulate cell fusions that contribute to typical skin changes.
The genetic vaccines currently in use program the recipient cells to produce these spiked proteins throughout the body. It is impossible to predict in which organs this occurs. It is therefore to be feared that the strong tendency for uncontrollable cell fusions triggered by the spiked proteins may lead to severe tissue damage and corresponding immunological and hematological consequences. Tissue destruction, microthrombosis and secondary immunological complications could lead to severe clinical pictures and death within a short period of time.
It is incomprehensible that the researchers at the Paul Ehrlich Institute, who studied and accurately described the dangers of spiked proteins, did not think about what genetic vaccines cause. The Institute is also responsible for the safety of genetically modified vaccines that supposedly produce these advanced proteins in the bodies of vaccinees.
However, such an obvious risk of vaccination is not even mentioned in the document.
Nor are there any known clinical studies that explicitly note or exclude such a risk with vaccines. Among the adverse side effects known to date, several could be explained by the fusion effect from the outside. Further research seems to be urgently warranted. Vaccinated persons with side effects should be entitled to immediate examination by an independent body. If such a risk has not been excluded, it would be another reason to immediately stop all genetic vaccines that allegedly lead to intracellular production and expression of surface proteins.
The Paul Ehrlich Institute further reports that, at least in the laboratory, cell fusions could be significantly reduced by administering monoclonal antibodies against surface proteins. Incidentally, Bill Gates mentioned large-scale genetic production of these monoclonal antibodies for mass treatment in December last year.
Surely no one would want that: complications from vaccines, which would then have to be treated again with expensive monoclonal antibodies.
Coronavirus vaccines do not have a big upside. Of the 19,000 people vaccinated in the already poor BioNTech study, there were only 154 fewer infections than of the 19,000 unvaccinated. Thus, the absolute risk of infection was reduced by less than 1 percent. In the vast majority of the population, there is cross-cellular immunity to anything resembling coronavirus, even without vaccination. Even if coronavirus infection were prevented by vaccination, other viruses would benefit. They would just get more space. Overall, critical reviews have also shown that vaccination against the ever-changing seasonal respiratory viruses brings few benefits, but significant risks.